FDA PMA
FDA Class 3
Approved
🇺🇸 United States
System, Colorectal Neoplasia, Rna Markers And Hemoglobin Detection
PMA: P230001
·
Supplement: S008
·
Decision Jul 3, 2025
Classifications
1
FEI Numbers
2
Registration Numbers
2
Basic Information
- Device Name
- System, Colorectal Neoplasia, Rna Markers And Hemoglobin Detection
- Trade Name
- ColoSense®
- PMA Number
- P230001
- Supplement Number
- S008
- Device Class
- FDA Class 3
- Product Code
- SBB
- Generic Name
- System, Colorectal Neoplasia, RNA Markers and Hemoglobin detection
- Medical Specialty
- Unknown
- Advisory Committee
- Pathology
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- July 3, 2025
- Date Received
- January 29, 2025
- Supplement Type
- Normal 180 Day Track No User Fee
- Supplement Reason
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Expedited Review
- N
Advisory Committee Statement
approval for a change in the contract packaging site location for the ColoSense Collection Kit
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| SBB | System, Colorectal Neoplasia, Rna Markers And Hemoglobin Detection | FDA class 3 | Unknown |